Differences in Ca 15-3 and Homocysteine Levels in Patients with Benign Tumor and Breast Cancer

Differences in Ca 15-3 and Homocysteine Levels in Patients with Benign Tumor and Breast Cancer

More than 25% of women have complaints related to breast lumps during their lifetime and approximately 12% have breast cancer. Cancer antigen 15-3 and homocysteine can be used as biomarkers in breast cancer. Breast cancer produces pro-inflammatory cytokines that can lead to increased CA 15-3 levels...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathink Toonov ANUGERAWATI, Indranila Kustarini SAMSURIA, I Edward Kurnia Setiawan LIMIJADI, Dwi RETNONINGRUM, Banundari RACHMAWATI
Format: Article
Language:English
Published: Bucharest College of Physicians 2024-03-01
Series:Modern Medicine
Subjects:
benign breast tumor
breast cancer
ca 15-3
homocysteine
Online Access:https://medicinamoderna.ro/wp-content/uploads/2024/03/Differences-in-Ca-15-3-and-Homocysteine-Levels-in-Patients-with-Benign-Tumor-and-Breast-Cancer.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://medicinamoderna.ro/wp-content/uploads/2024/03/Differences-in-Ca-15-3-and-Homocysteine-Levels-in-Patients-with-Benign-Tumor-and-Breast-Cancer.pdf

Similar Items